September 2025

Ad Lentus Laboratories GmbH initiated a collaborative project in Morocco for the implementation of dendritic cell therapies and stem cell banking. The project includes technology transfer, GMP-compliant manufacturing structures and the development of local capabilities for advanced cell therapies.

January 2021

On behalf of Shanghai Cell Biotech Co. Ltd., Ad Lentus Laboratories GmbH was tasked with the on-site instruction and training of personnel in a GMP-compliant manufacturing process for human autologous cell therapeutics.

November 2020

Following extensive preparation and regulatory coordination, Weiss Klimatechnik GmbH was commissioned by Ad Lentus Laboratories GmbH to carry out GMP-compliant construction measures for two cleanrooms (Grade A in B) at the Laichingen facility, in full accordance with Annex 1 of the EU GMP guidelines.